Florian Loher

491 total citations
8 papers, 436 citations indexed

About

Florian Loher is a scholar working on Surgery, Genetics and Oncology. According to data from OpenAlex, Florian Loher has authored 8 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Genetics and 2 papers in Oncology. Recurrent topics in Florian Loher's work include Helicobacter pylori-related gastroenterology studies (3 papers), Inflammatory Bowel Disease (3 papers) and Cell Adhesion Molecules Research (2 papers). Florian Loher is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (3 papers), Inflammatory Bowel Disease (3 papers) and Cell Adhesion Molecules Research (2 papers). Florian Loher collaborates with scholars based in Germany and Switzerland. Florian Loher's co-authors include Andreas Eigler, Stefan Endres, Britta Siegmund, M Dauer, Christian Bauer, Christian Ries, Manfred G. Ismair, Petro E. Petrides, Chuanbing Zang and Hans A. Lehr and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Leukemia and Digestive Diseases and Sciences.

In The Last Decade

Florian Loher

8 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Loher Germany 6 220 152 77 71 64 8 436
Yueping Sun China 12 330 1.5× 257 1.7× 84 1.1× 101 1.4× 44 0.7× 20 718
Odile Wéra Belgium 8 137 0.6× 180 1.2× 27 0.4× 26 0.4× 50 0.8× 13 407
Cynthia Zajac United States 11 228 1.0× 173 1.1× 87 1.1× 30 0.4× 22 0.3× 20 404
Yongnian Liu China 15 300 1.4× 259 1.7× 71 0.9× 67 0.9× 29 0.5× 33 591
Youxian Li Japan 8 185 0.8× 247 1.6× 16 0.2× 89 1.3× 50 0.8× 10 667
Donald Chow United States 15 291 1.3× 74 0.5× 45 0.6× 73 1.0× 52 0.8× 29 549
David Millrine United Kingdom 14 400 1.8× 192 1.3× 67 0.9× 107 1.5× 22 0.3× 18 696
Jeanette Osban United States 9 202 0.9× 244 1.6× 87 1.1× 58 0.8× 24 0.4× 9 552
Carolyn R. Weiss Canada 11 189 0.9× 243 1.6× 14 0.2× 47 0.7× 75 1.2× 15 504
Tanzilya Khayrullina United States 6 133 0.6× 363 2.4× 20 0.3× 78 1.1× 58 0.9× 7 689

Countries citing papers authored by Florian Loher

Since Specialization
Citations

This map shows the geographic impact of Florian Loher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Loher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Loher more than expected).

Fields of papers citing papers by Florian Loher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Loher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Loher. The network helps show where Florian Loher may publish in the future.

Co-authorship network of co-authors of Florian Loher

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Loher. A scholar is included among the top collaborators of Florian Loher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Loher. Florian Loher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bauer, Christian, Florian Loher, M Dauer, et al.. (2007). The ICE Inhibitor Pralnacasan Prevents DSS-Induced Colitis in C57BL/6 Mice and Suppresses IP-10 mRNA but Not TNF-α mRNA Expression. Digestive Diseases and Sciences. 52(7). 1642–1652. 67 indexed citations
2.
Loher, Florian, Christian Bauer, Britta Siegmund, et al.. (2004). The Interleukin-1β-Converting Enzyme Inhibitor Pralnacasan Reduces Dextran Sulfate Sodium-Induced Murine Colitis and T Helper 1 T-Cell Activation. Journal of Pharmacology and Experimental Therapeutics. 308(2). 583–590. 97 indexed citations
3.
Loher, Florian, Christian Bauer, Britta Siegmund, et al.. (2003). The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice. Journal of Pharmacology and Experimental Therapeutics. 305(2). 549–556. 35 indexed citations
4.
Schulze, Johannes, et al.. (2002). Determination of thiopurine S-methyltransferase phenotype using thin-layer chromatography and quantitative scanning. European Journal of Clinical Pharmacology. 58(1). 41–44. 4 indexed citations
5.
Siegmund, Britta, Florian Rieder, Stefan Albrich, et al.. (2001). Adenosine Kinase Inhibitor GP515 Improves Experimental Colitis in Mice. Journal of Pharmacology and Experimental Therapeutics. 296(1). 99–105. 120 indexed citations
6.
Siegmund, Britta, Florian Loher, Gudrun Meinhardt, et al.. (2001). Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis. Leukemia. 15(10). 1564–1571. 19 indexed citations
7.
Eigler, Andreas, Florian Loher, & Stefan Endres. (2001). Suppression der Synthese des Tumornekrosefaktors. Der Internist. 42(1). 28–34. 3 indexed citations
8.
Ries, Christian, Florian Loher, Chuanbing Zang, Manfred G. Ismair, & Petro E. Petrides. (1999). Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.. PubMed. 5(5). 1115–24. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026